Feb 12, 2015 at 20:56 | Source: PTI
"Pursuant to the global deal, the company will have its distribution rights terminated for the oncology portfolio in return for accessing the distribution rights of the acquired vaccines portfolio," GlaxoSmithKline Pharmaceuticals Ltd said in a filing to the BSE.
Feb 12, 2015 at 14:13 | Source: Moneycontrol.com
Its EBITDA was flat at Rs 115 crore versus Rs 118 crore.
Dec 24, 2014 at 14:37 | Source: PTI
Shares of Novartis India gained over 5 percent today after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.
Dec 24, 2014 at 08:20 | Source: CNBC-TV18
UltraTech Cement | Jaiprakash Associates | Sobha | IFCI | NTPC | Alstom T&D India | Electrosteel Castings | Ambuja Cements | Manappuram Finance | Godrej Industries | Claris Lifesciences | Fulford India | Novartis | GSK Pharma | Nirlon | Future Retail | TTK Healthcare | MCX | IOC and MTNL are stocks, which are in the news today.
Dec 23, 2014 at 20:21 | Source: PTI
The multi-layered deal involves UK-based GlaxoSmithKline (GSK) acquiring the Swiss major's vaccine business, while the latter would purchase GSK's cancer drugs portfolio.
Nov 17, 2014 at 20:49 | Source: CNBC-TV18
NSE FinWiz at GlaxoSmithKline (GSK) Pharmaceuticals, Mumbai to gauge financial planning thoughts and notions of the young employees on investments and financial planning.
Nov 12, 2014 at 12:00 | Source: Moneycontrol.com
Aurobindo Pharma gained 3.7 percent after the company's US subsidiary emerged as highest bidder to acquire Natrol with bid of USD 132.5 million.
Nov 07, 2014 at 08:36 | Source: CNBC-TV18
Bharti Airtel | Infosys | Ranbaxy Labs | Sun Pharma | Hero Motocorp | Larsen and Toubro | Marico | Arvind | Jet Airways | ONGC | DLF | Financial Tech | JSW Steel | Axis Bank | MTNL | Edelweiss | Suzlon | Ashok Leyland | GSK Pharma | Canara Bank | Indian Bank | IRB Infrastructure and Karur Vysya Bank are stocks, which are in the news today.
Nov 06, 2014 at 14:09 | Source: PTI
Standalone total income from operations of GSK Pharma rose to Rs 746.76 crore for the quarter under consideration from Rs 626.65 crore for the same period year-ago
Oct 11, 2014 at 14:53 | Source: Moneycontrol.com
Analysts at Motilal Oswal believe that Lupin, Ranbaxy, Cadila Healthcare, GSK Pharma, Torrent Pharma and Alembic Pharma will report stronger overall operational performance during this quarter.